About Cytek Biosciences, Inc. 
Cytek Biosciences, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 49 Schemes (30.97%)
Foreign Institutions
Held by 76 Foreign Institutions (8.85%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
46 Million
(Quarterly Results - Jun 2025)
Net Profit:
-6 Million
Pharmaceuticals & Biotechnology
USD 522 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.64
-4.14%
1.38






